OR WAIT null SECS
The HCPLive insomnia page is a comprehensive resource for clinical news and insights on sleeplessness. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for insomnia, and more.
February 19, 2024
Article
A new study found non-hospitalized COVID-19 survivors from a Vietnam general population had a 76.1% prevalence of insomnia, with 22.8% of respondents with insomnia scoring for severe insomnia.
February 09, 2024
Multivariable analyses found genetic predispositions to overall rheumatoid arthritis with decreased sleep duration, as well as a significant genetic association between seropositive rheumatoid arthritis and insomnia symptoms.
January 23, 2024
Male college students were found to consume more energy drinks than female college students, and they had a greater risk for a short sleep duration due to energy drink consumption.
January 19, 2024
A new study found critical components of CBT-I are cognitive restructuring, third-wave components, sleep restrictions, and stimulus control.
January 18, 2024
Investigators observed no change in Insomnia Severity Index scores from baseline to weeks 7 and 25 with CBT-1, trazodone, or placebo, suggesting these insomnia treatment options are not effective for patients undergoing hemodialysis.
January 02, 2024
A new study found patients who scored high on the Insomnia Severity Index questionnaire had a longer hospital stay length, increased risk of 30-day readmission, and increased risk of 30-day emergency department or urgent care visits.
December 30, 2023
A nationwide Taiwan-based study found benzodiazepine use during pregnancy was linked to roughly a 70% increased risk of miscarriage.
December 13, 2023
Late shift work is associated with sleep disorders the most for females, the age group
October 10, 2023
In the second index, REM fragmentation decreased more in the SRT group than the control group, but in other indexes, there was not a statistical difference.
August 25, 2023
A proof-of-concept trial shows a program that addresses sleep pressure, circadian rhythm and hyperarousal in adolescents and young adults receiving mental health care is promising.